These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 34137531
1. Management Of Childhood Steroid Dependent Nephrotic Syndrome With Cyclophosphamide - An Experience At Ayub Teaching Hospital, Abbottabad. Hussain Shah SS, Aalia B, Raza A, Najeeb S, Rehman AU. J Ayub Med Coll Abbottabad; 2021; 33(2):213-216. PubMed ID: 34137531 [Abstract] [Full Text] [Related]
3. Long-term follow-up after cyclophosphamide therapy in steroid-dependent nephrotic syndrome. Zagury A, de Oliveira AL, de Moraes CA, de Araujo Montalvão JA, Novaes RH, de Sá VM, Monteiro de Carvalho Dde B, Matuck T. Pediatr Nephrol; 2011 Jun; 26(6):915-20. PubMed ID: 21399901 [Abstract] [Full Text] [Related]
4. Unfavorable response to cyclophosphamide in steroid-dependent nephrotic syndrome. Kemper MJ, Altrogge H, Ludwig K, Timmermann K, Müller-Wiefel DE. Pediatr Nephrol; 2000 Aug; 14(8-9):772-5. PubMed ID: 10955925 [Abstract] [Full Text] [Related]
5. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome. Kyrieleis HA, Levtchenko EN, Wetzels JF. Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840 [Abstract] [Full Text] [Related]
6. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT. Webb NJ, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Wheatley K, Ives NJ. Health Technol Assess; 2019 May; 23(26):1-108. PubMed ID: 31156083 [Abstract] [Full Text] [Related]
7. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial. Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R, Lama G, Zacchello G, Confalonieri R, Altieri P. Nephrol Dial Transplant; 1993 May; 8(12):1326-32. PubMed ID: 8159300 [Abstract] [Full Text] [Related]
8. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus. Sinha MD, MacLeod R, Rigby E, Clark AG. Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257 [Abstract] [Full Text] [Related]
9. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome. Bagga A, Hari P, Moudgil A, Jordan SC. Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181 [Abstract] [Full Text] [Related]
10. Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome. Mizutani A, Fujinaga S, Sakuraya K, Hirano D, Shimizu T. Clin Exp Nephrol; 2019 Feb; 23(2):244-250. PubMed ID: 30121800 [Abstract] [Full Text] [Related]
11. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience. El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M. Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303 [Abstract] [Full Text] [Related]
12. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome]. Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases. Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389 [Abstract] [Full Text] [Related]
13. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07). Horinouchi T, Sako M, Nakanishi K, Ishikura K, Ito S, Nakamura H, Oba MS, Nozu K, Iijima K. BMC Nephrol; 2018 Nov 01; 19(1):302. PubMed ID: 30382824 [Abstract] [Full Text] [Related]
14. Long-term follow-up in children with steroid-resistant nephrotic syndrome. Besbas N, Topaloglu R, Saatci O, Bakkaloglu A. Clin Pediatr (Phila); 1992 May 01; 31(5):283-8. PubMed ID: 1582094 [Abstract] [Full Text] [Related]
15. Intravenous cyclophosphamide is the drug of choice for steroid dependent nephrotic syndrome. Bircan Z, Kara B. Pediatr Int; 2003 Feb 01; 45(1):65-7. PubMed ID: 12654072 [Abstract] [Full Text] [Related]
16. Follow-up of steroid-resistant nephrotic syndrome: tubular proteinuria and enzymuria. Vallés P, Peralta M, Carrizo L, Martin L, Principi I, Gonzalez A, Manucha W. Pediatr Nephrol; 2000 Dec 01; 15(3-4):252-8. PubMed ID: 11149121 [Abstract] [Full Text] [Related]
17. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome. Wang J, Mao J, Chen J, Fu H, Shen H, Zhu X, Liu A, Shu Q, Du L. Nephrology (Carlton); 2016 Jan 01; 21(1):21-7. PubMed ID: 26697959 [Abstract] [Full Text] [Related]
18. Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome. Ueda N, Takahashi K, Akioka Y, Morooka M, Ogawa A, Tsuzuki K. J Nephrol; 2009 Jan 01; 22(5):610-5. PubMed ID: 19809993 [Abstract] [Full Text] [Related]
19. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report]. Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA. Przegl Lek; 2006 Jan 01; 63 Suppl 3():44-8. PubMed ID: 16898486 [Abstract] [Full Text] [Related]
20. Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine. Fujinaga S, Hirano D, Nishino T, Umeda C, Watanabe Y, Nakagawa M. Pediatr Nephrol; 2019 Nov 01; 34(11):2417-2421. PubMed ID: 31435725 [Abstract] [Full Text] [Related] Page: [Next] [New Search]